A Clinical study on the Effect of Peritoneal Dialysis and Hemodialysis on the Microinflammatory State and Quality of Life in Patients with Chronic Renal Failure
Qiu-yuan SHAO,Miao ZHANG,Qing-yan ZHANG,Min ZHAO,Cheng WAN,Zheng SUN,Heng-jin WANG
DOI: https://doi.org/10.13241/j.cnki.pmb.2018.13.016
2018-01-01
Abstract:Objective: To compare the effects of peritoneal dialysis and hemodialysis on the microinflammatory state and quality of life of patients with chronic renal failure. Methods: From November 2014 to September 2016, 96 cases of patients with chronic renal failure were selected and divided into the observation group and the control group according to the order of admission, with 48 cases in each group, the observation group was treated with peritoneal dialysis, the control group was treated with hemodialysis, the levels of serum hs-CRP (hs-C-reactive protein), interleukin-6 (IL-6) and Tumor necrosis factor-α (TNF-α), blood urea nitrogen (BUN), serum creatinine (Scr) and albumin albumin (ALB) levels, hemoglobin (HB) and red blood cell (RBC), SF-36 scale and the incidence of complications were compared between two groups before and after treatment. Results: After treatment, the levels of serum hs-CRP, IL-6, TNF-α, BUN, Scr and ALB were significantly lower in the observation group than those in the control group, the HB and RBC levels were significantly higher than those in the control group (P ＜0.05). The incidence of cardiovascular and cerebrovascular disease in the observation group was significantly lower than that in the control group, and the incidence of hypoalbuminemia and infection was significantly higher than that of the control group (P＜0.05); but there was no significant difference in the incidence of total complications between the two groups (P＞0.05). there was no significant difference in the physical function, overall health and mental health score between two groups (P＞0.05), the body pain, vitality, social function, physiological function and emotional function score were significantly higher than those of the control group (P ＜0.05). Conclusion: Peritoneal dialysis was more effective in the treatment of patients with chronic renal failure than hemodialysis, which couldeffectively inhibit the microinflammatory state of patients, improve the clearance rate of small molecules, quality of life and reduce the incidence of cardiovascular and cerebrovascular diseases, but the treatment is easy to induce hypoproteinemia and infection and other complications, prompt addition of albumin and prevention of infection and other symptomatic treatment were needed during the treatment.